4291 - 4300 of 8808 Results
Title
Year
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 37
-
OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://www.prd-journal.com/article/S1353802020300973/pdfCitation Count: 46
-
RESTRICTEDTitle: Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 739Issue #:Start Page: 135443End Page: 135443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2020.135443Citation Count: 9
-
RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 39
-
OPENTitle: Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular PathwaysJournal Name: NeuronPublisher: Elsevier BVVol: 106Issue #: 5Start Page: 727End Page: 742.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2020.02.034Best OA location URL: http://www.cell.com/article/S0896627320301859/pdfCitation Count: 202
-
OPENTitle: New transgenic models of Parkinson's disease using genome editing technologyJournal Name: Neurología (English Edition)Publisher: Elsevier BVVol: 35Issue #: 7Start Page: 486End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006Best OA location URL: https://doi.org/10.1016/j.nrleng.2017.08.006Citation Count: 3
-
OPENTitle: Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applicationsJournal Name: NeurocomputingPublisher: Elsevier BVVol: 410Issue #:Start Page: 237End Page: 270Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neucom.2020.05.078Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0925231220309292Citation Count: 240
-
OPENTitle: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104623End Page: 104623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996119302980?via%3DihubCitation Count: 80
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 35
-
OPENTitle: Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273RJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105079End Page: 105079Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105079Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105079Citation Count: 5